Mars and CVS Health Named End User Award Winners at 2026 NextGen Conference
Global confectionery and petcare company Mars and pharmacy innovation leader CVS Health will be recognized at the 2026 NextGen Supply Chain Conference for successfully applying artificial intelligence, automation and operational excellence to their supply chains. The awards, part of the annual End User Awards program, celebrate companies that have moved technology from pilot to measurable business impact.
The presentation will take place during the opening general session on Thursday, October 22, at the W Nashville in downtown Nashville. The conference runs October 21–23 and is sponsored by Zion Solutions Group. Attendees will have the chance to hear directly from the practitioners who led the transformation initiatives at both organizations, gaining insights into real-world deployment and scaling.
While the official announcement does not disclose specific metrics, the recognition underscores the growing emphasis on execution over innovation for its own sake — a theme that conference organizers have placed at the center of the 2026 event.
What the Recognitions Reveal About Supply Chain Innovation Trends
Mars and CVS Health: Two Paths to Operational Excellence
The selection of Mars and CVS Health presents two distinct case studies. Mars, with its complex global network of raw materials and finished goods, likely leveraged AI for demand sensing and autonomous planning. CVS Health, operating a heavily regulated and precision-driven pharmacy supply chain, likely focused on warehouse automation and fulfillment accuracy. Both represent the maturation of intelligent supply chain technologies beyond early adopter hype.
The award program’s emphasis on “measurable business outcomes” suggests that judges prioritized demonstrable ROI — cost savings, service level improvements or speed-to-market gains — over technical novelty. For logistics professionals, the takeaway is clear: the conversation is shifting from what’s possible to what’s proven and replicable.
Comments 0